[Mud treatment of patients with rheumatoid arthritis with an immunologic deficiency]

The response to pelotherapy has been assessed clinically and immunologically basing on T-lymphocyte count. Altogether 124 rheumatoid arthritis (RA) patients were examined. In patients with low baseline levels of T-lymphocytes the effect of pelotherapy appeared inferior to that in patients with normal T-lymphocyte counts. It was suggested that T-cell immunosuppressed RA patients should receive combined therapy with mud applications and anabolic stimulator potassium orotate.